These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 6436869

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Lack of effect of hyperglycaemia on apomorphine induced growth hormone release in normal man.
    Nilsson KO.
    Acta Endocrinol (Copenh); 1975 Oct; 80(2):230-6. PubMed ID: 1242266
    [Abstract] [Full Text] [Related]

  • 4. Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy.
    Ettigi P, Nair NP, Lal S, Cervantes P, Guyda H.
    J Neurol Neurosurg Psychiatry; 1976 Sep; 39(9):870-6. PubMed ID: 993808
    [Abstract] [Full Text] [Related]

  • 5. Relation of clinical symptoms to apomorphine-stimulated growth hormone release in mood-incongruent psychotic patients.
    Zemlan FP, Hirschowitz J, Garver DL.
    Arch Gen Psychiatry; 1986 Dec; 43(12):1162-7. PubMed ID: 3778112
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of dopamine agonists and haloperidol on release of prolactin, thyroid stimulating hormone, growth hormone and luteinizing hormone in rats.
    Mueller GP, Simpkins J, Meites J, Moore KE.
    Neuroendocrinology; 1976 Dec; 20(2):121-35. PubMed ID: 958594
    [Abstract] [Full Text] [Related]

  • 7. The effect of methyltestosterone on the growth hormone response to the dopamine receptor agonist, apomorphine.
    Lal S, Nair NP, Thavundayil JX, Tawar V, Guyda H, Ayotte C.
    Prog Neuropsychopharmacol Biol Psychiatry; 1991 Dec; 15(2):263-8. PubMed ID: 1871327
    [Abstract] [Full Text] [Related]

  • 8. In vitro and in vivo evidence that dopamine exerts growth hormone-releasing activity in goldfish.
    Wong AO, Chang JP, Peter RE.
    Am J Physiol; 1993 Jun; 264(6 Pt 1):E925-32. PubMed ID: 8101429
    [Abstract] [Full Text] [Related]

  • 9. Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Relation to duration of illness and depressive symptoms.
    Meltzer HY, Kolakowska T, Fang VS, Fogg L, Robertson A, Lewine R, Strahilevitz M, Busch D.
    Arch Gen Psychiatry; 1984 May; 41(5):512-9. PubMed ID: 6721674
    [Abstract] [Full Text] [Related]

  • 10. Effect of L-tryptophan on apomorphine-induced growth hormone secretion in normal subjects.
    Lal S, Young SN, Cervantes P, Guyda H.
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Nov; 13(6):331-5. PubMed ID: 7208604
    [Abstract] [Full Text] [Related]

  • 11. CCK-8 antagonizes apomorphine-induced growth hormone secretion in normal subjects.
    Nair NP, Lal S, Eugenio H, Lizondo E, Thavundayil JX, Wood PL, Etienne P, Guyda H.
    Horm Metab Res; 1986 Jan; 18(1):53-5. PubMed ID: 3949282
    [Abstract] [Full Text] [Related]

  • 12. Effect of previous antidepressant therapy on the growth hormone response to apomorphine.
    Pitchot W, Hansenne M, Gonzalez Moreno A, Ansseau M.
    Neuropsychobiology; 1995 Jan; 32(1):19-22. PubMed ID: 7566518
    [Abstract] [Full Text] [Related]

  • 13. Growth hormone and gonadotropin secretion in the common carp (Cyprinus carpio L.): in vitro interactions of gonadotropin-releasing hormone, somatostatin, and the dopamine agonist apomorphine.
    Lin XW, Lin HR, Peter RE.
    Gen Comp Endocrinol; 1993 Jan; 89(1):62-71. PubMed ID: 8094060
    [Abstract] [Full Text] [Related]

  • 14. Blunted response of growth hormone to clonidine and apomorphine in endogenous depression.
    Ansseau M, Von Frenckell R, Cerfontaine JL, Papart P, Franck G, Timsit-Berthier M, Geenen V, Legros JJ.
    Br J Psychiatry; 1988 Jul; 153():65-71. PubMed ID: 3224252
    [Abstract] [Full Text] [Related]

  • 15. Effectof sex, oral contraceptives, and glucose loading on apomorphine-induced growth hormone secretion.
    Ettigi P, Lal S, Martin JB, Friesen HG.
    J Clin Endocrinol Metab; 1975 Jun; 40(6):1094-8. PubMed ID: 1133158
    [Abstract] [Full Text] [Related]

  • 16. Effect of apomorphine on melatonin secretion in normal subjects.
    Lal S, Isaac I, Pilapil C, Nair NP, Hariharasubramanian N, Guyda H, Quirion R.
    Prog Neuropsychopharmacol Biol Psychiatry; 1987 Jun; 11(2-3):229-33. PubMed ID: 3628830
    [Abstract] [Full Text] [Related]

  • 17. The blunted plasma cortisol response to apomorphine and its relationship to treatment response in patients with schizophrenia.
    Meltzer HY, Lee MA, Jayathilake K.
    Neuropsychopharmacology; 2001 Mar; 24(3):278-90. PubMed ID: 11166518
    [Abstract] [Full Text] [Related]

  • 18. Increased growth hormone response to apomorphine in Parkinson disease compared with multiple system atrophy.
    Friess E, Kuempfel T, Winkelmann J, Schmid D, Uhr M, Rupprecht R, Holsboer F, Trenkwalder C.
    Arch Neurol; 2001 Feb; 58(2):241-6. PubMed ID: 11176962
    [Abstract] [Full Text] [Related]

  • 19. Reduced growth hormone response to apomorphine in schizophrenic patients with poor premorbid social functioning.
    Malas KL, van Kammen DP, de Fraites EA, Brown GM, Gold PW.
    J Neural Transm; 1987 Feb; 69(3-4):319-24. PubMed ID: 3625198
    [Abstract] [Full Text] [Related]

  • 20. Modulation of dopamine-mediated behavioural responses by antidepressants: effects of single and repeated treatment.
    Delini-Stula A, Vassout A.
    Eur J Pharmacol; 1979 Oct 15; 58(4):443-51. PubMed ID: 574454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.